57th Urology Course posted on LinkedIn:
“Debate: Bladder preservation in muscle-invasive bladder cancer. Bladder preservation in MIBC. Results and cost.
Pro- T. Powles
Con- A. Kamat
Which side are you?
- innovation
- improvement
- integration.”
Shared their own post adding:
“Neoadjuvant treatment + bladder preservation in MIBC? UroONCO 2 on the spot
PRO Tom Powles ctDNA to select pts for bladder preservation after IO. It’s here, it’s now.
CON Ashish M. Kamat small % of pts, no consensus on follow-up the future/not the present.”